Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Olli Kallioniemi

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Procedures

Devices

Oligonucleotide Array Sequence Analysis

Physiology

Concepts & Ideas

Genes & Molecular Sequences

BRCA1 Genes

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Nevo Jonna; Mattila Elina; Pellinen Teijo; Yamamoto Daniel L; Sara Henri; Iljin Kristiina; Kallioniemi Olli; Bono Petri; Heikkilä Päivi; Joensuu Heikki; Wärri Anni; Ivaska Johanna
Mammary-derived growth inhibitor alters traffic of EGFR and induces a novel form of cetuximab resistance.
Leivonen S-K; Mäkelä R; Ostling P; Kohonen P; Haapa-Paananen S; Kleivi K; Enerly E; Aakula A; Hellström K; Sahlberg N; Kristensen V N; Børresen-Dale A-L; Saviranta P; Perälä M; Kallioniemi O
Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines.
Iljin Kristiina; Ketola Kirsi; Vainio Paula; Halonen Pasi; Kohonen Pekka; Fey Vidal; Grafström Roland C; Perälä Merja; Kallioniemi Olli
High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Olli Kallioniemi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Nevo Jonna; Mattila Elina; Pellinen Teijo; Yamamoto Daniel L; Sara Henri; Iljin Kristiina; Kallioniemi Olli; Bono Petri; Heikkilä Päivi; Joensuu Heikki; Wärri Anni; Ivaska Johanna
Mammary-derived growth inhibitor alters traffic of EGFR and induces a novel form of cetuximab resistance.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(21):6570-81.
2009: Leivonen S-K; Mäkelä R; Ostling P; Kohonen P; Haapa-Paananen S; Kleivi K; Enerly E; Aakula A; Hellström K; Sahlberg N; Kristensen V N; Børresen-Dale A-L; Saviranta P; Perälä M; Kallioniemi O
Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines.
Oncogene 2009;28(44):3926-36.
2009: Iljin Kristiina; Ketola Kirsi; Vainio Paula; Halonen Pasi; Kohonen Pekka; Fey Vidal; Grafström Roland C; Perälä Merja; Kallioniemi Olli
High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(19):6070-8.
2009: Côme Christophe; Laine Anni; Chanrion Maïa; Edgren Henrik; Mattila Elina; Liu Xiaoling; Jonkers Jos; Ivaska Johanna; Isola Jorma; Darbon Jean-Marie; Kallioniemi Olli; Thézenas Simon; Westermarck Jukka
CIP2A is associated with human breast cancer aggressivity.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(16):5092-100.
2009: Salmela Anna-Leena; Pouwels Jeroen; Varis Asta; Kukkonen Anu M; Toivonen Pauliina; Halonen Pasi K; Perälä Merja; Kallioniemi Olli; Gorbsky Gary J; Kallio Marko J
Dietary flavonoid fisetin induces a forced exit from mitosis by targeting the mitotic spindle checkpoint.
Carcinogenesis 2009;30(6):1032-40.
2009: Brennan Donal J; Ek Sara; Doyle Emma; Drew Thomas; Foley Michael; Flannelly Grainne; O'Connor Darran P; Gallagher William M; Kilpinen Sami; Kallioniemi Olli-Pekka; Jirstrom Karin; O'Herlihy Colm; Borrebaeck Carl A K
The transcription factor Sox11 is a prognostic factor for improved recurrence-free survival in epithelial ovarian cancer.
European journal of cancer (Oxford, England : 1990) 2009;45(8):1510-7.
2009: Tiikkainen Pekka; Poso Antti; Kallioniemi Olli
Comparison of structure fingerprint and molecular interaction field based methods in explaining biological similarity of small molecules in cell-based screens.
Journal of computer-aided molecular design 2009;23(4):227-39.
2009: Aebersold Ruedi; Auffray Charles; Baney Erin; Barillot Emmanuel; Brazma Alvis; Brett Catherine; Brunak Søren; Butte Atul; Califano Andrea; Celis Julio; Cufer Tanja; Ferrell James; Galas David; Gallahan Daniel; Gatenby Robert; Goldbeter Albert; Hace Natasa; Henney Adriano; Hood Lee; Iyengar Ravi; Jackson Vicky; Kallioniemi Ollie; Klingmüller Ursula; Kolar Patrik; Kolch Walter; Kyriakopoulou Christina; Laplace Frank; Lehrach Hans; Marcus Frederick; Matrisian Lynn; Nolan Garry; Pelkmans Lucas; Potti Anil; Sander Chris; Seljak Marija; Singer Dinah; Sorger Peter; Stunnenberg Hendrik; Superti-Furga Giulio; Uhlen Mathias; Vidal Marc; Weinstein John; Wigle Dennis; Williams Michael; Wolkenhauer Olaf; Zhivotovsky Boris; Zinovyev Andrei; Zupan Blaz
Report on EU-USA workshop: how systems biology can advance cancer research (27 October 2008).
Molecular oncology 2009;3(1):9-17.
2009: Muggerud Aslaug Aamodt; Edgren Henrik; Wolf Maija; Kleivi Kristine; Dejeux Emelyne; Tost Jörg; Sørlie Therese; Kallioniemi Olli
Data integration from two microarray platforms identifies bi-allelic genetic inactivation of RIC8A in a breast cancer cell line.
BMC medical genomics 2009;2():26.
2009: Autio Reija; Kilpinen Sami; Saarela Matti; Kallioniemi Olli; Hautaniemi Sampsa; Astola Jaakko
Comparison of Affymetrix data normalization methods using 6,926 experiments across five array generations.
BMC bioinformatics 2009;10 Suppl 1():S24.
2008: Björkman Mari; Iljin Kristiina; Halonen Pasi; Sara Henri; Kaivanto Elisa; Nees Matthias; Kallioniemi Olli P
Defining the molecular action of HDAC inhibitors and synergism with androgen deprivation in ERG-positive prostate cancer.
International journal of cancer. Journal international du cancer 2008;123(12):2774-81.
2008: Pellinen Teijo; Tuomi Saara; Arjonen Antti; Wolf Maija; Edgren Henrik; Meyer Hannelore; Grosse Robert; Kitzing Thomas; Rantala Juha K; Kallioniemi Olli; Fässler Reinhard; Kallio Marko; Ivaska Johanna
Integrin trafficking regulated by Rab21 is necessary for cytokinesis.
Developmental cell 2008;15(3):371-85.
2008: Basu Gargi D; Azorsa David O; Kiefer Jeffrey A; Rojas Angela M; Tuzmen Sukru; Barrett Michael T; Trent Jeffrey M; Kallioniemi Olli; Mousses Spyro
Functional evidence implicating S100P in prostate cancer progression.
International journal of cancer. Journal international du cancer 2008;123(2):330-9.
2008: Sundvall Maria; Iljin Kristiina; Kilpinen Sami; Sara Henri; Kallioniemi Olli-Pekka; Elenius Klaus
Role of ErbB4 in breast cancer.
Journal of mammary gland biology and neoplasia 2008;13(2):259-68.
2008: Varjosalo Markku; Björklund Mikael; Cheng Fang; Syvänen Heidi; Kivioja Teemu; Kilpinen Sami; Sun Zairen; Kallioniemi Olli; Stunnenberg Hendrik G; He Wei-Wu; Ojala Päivi; Taipale Jussi
Application of active and kinase-deficient kinome collection for identification of kinases regulating hedgehog signaling.
Cell 2008;133(3):537-48.
2008: Antoniou A C; Cunningham A P; Peto J; Evans D G; Lalloo F; Narod S A; Risch H A; Eyfjord J E; Hopper J L; Southey M C; Olsson H; Johannsson O; Borg A; Pasini B; Radice P; Manoukian S; Eccles D M; Tang N; Olah E; Anton-Culver H; Warner E; Lubinski J; Gronwald J; Gorski B; Tryggvadottir L; Syrjakoski K; Kallioniemi O-P; Eerola H; Nevanlinna H; Pharoah P D P; Easton D F
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions.
British journal of cancer 2008;98(8):1457-66.
2008: Kilpinen Sami; Autio Reija; Ojala Kalle; Iljin Kristiina; Bucher Elmar; Sara Henri; Pisto Tommi; Saarela Matti; Skotheim Rolf I; Björkman Mari; Mpindi John-Patrick; Haapa-Paananen Saija; Vainio Paula; Edgren Henrik; Wolf Maija; Astola Jaakko; Nees Matthias; Hautaniemi Sampsa; Kallioniemi Olli
Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissues.
Genome biology 2008;9(9):R139.
2007: Pylkäs Katri; Tommiska Johanna; Syrjäkoski Kirsi; Kere Juha; Gatei Magtouf; Waddell Nicola; Allinen Minna; Karppinen Sanna-Maria; Rapakko Katrin; Kääriäinen Helena; Aittomäki Kristiina; Blomqvist Carl; Mustonen Aki; Holli Kaija; Khanna Kum Kum; Kallioniemi Olli-Pekka; Nevanlinna Heli; Winqvist Robert
Evaluation of the role of Finnish ataxia-telangiectasia mutations in hereditary predisposition to breast cancer.
Carcinogenesis 2007;28(5):1040-5.
2007: Leotlela P D; Wade M S; Duray P H; Rhode M J; Brown H F; Rosenthal D T; Dissanayake S K; Earley R; Indig F E; Nickoloff B J; Taub D D; Kallioniemi O P; Meltzer P; Morin P J; Weeraratna A T
Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility.
Oncogene 2007;26(26):3846-56.
2007: Taussig Michael J; Stoevesandt Oda; Borrebaeck Carl A K; Bradbury Andrew R; Cahill Dolores; Cambillau Christian; de Daruvar Antoine; Dübel Stefan; Eichler Jutta; Frank Ronald; Gibson Toby J; Gloriam David; Gold Larry; Herberg Friedrich W; Hermjakob Henning; Hoheisel Jörg D; Joos Thomas O; Kallioniemi Olli; Koegl Manfred; Konthur Zoltán; Korn Bernhard; Kremmer Elisabeth; Krobitsch Sylvia; Landegren Ulf; van der Maarel Silvère; McCafferty John; Muyldermans Serge; Nygren Per-Ake; Palcy Sandrine; Plückthun Andreas; Polic Bojan; Przybylski Michael; Saviranta Petri; Sawyer Alan; Sherman David J; Skerra Arne; Templin Markus; Ueffing Marius; Uhlén Mathias
ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome.
Nature methods 2007;4(1):13-7.
2007: Wicker Nicolas; Carles Annaïck; Mills Ian G; Wolf Maija; Veerakumarasivam Abhi; Edgren Henrik; Boileau Fabrice; Wasylyk Bohdan; Schalken Jack A; Neal David E; Kallioniemi Olli; Poch Olivier
A new look towards BAC-based array CGH through a comprehensive comparison with oligo-based array CGH.
BMC genomics 2007;8():84.
2006: Edgren Henrik; Kallioniemi Olli
Integrated breast cancer genomics.
Cancer cell 2006;10(6):453-4.
2006: Iljin Kristiina; Wolf Maija; Edgren Henrik; Gupta Santosh; Kilpinen Sami; Skotheim Rolf I; Peltola Mari; Smit Frank; Verhaegh Gerald; Schalken Jack; Nees Matthias; Kallioniemi Olli
TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming.
Cancer research 2006;66(21):10242-6.
2006: Järvinen A-K; Autio R; Haapa-Paananen S; Wolf M; Saarela M; Grénman R; Leivo I; Kallioniemi O; Mäkitie A A; Monni O
Identification of target genes in laryngeal squamous cell carcinoma by high-resolution copy number and gene expression microarray analyses.
Oncogene 2006;25(52):6997-7008.
2006: Saviranta Petri; Kallioniemi Olli
Human Protein Atlas charts a diverse terrain.
Trends in biotechnology 2006;24(5):195-7.
2006: Vahteristo Pia; Syrjäkoski Kirsi; Heikkinen Tuomas; Eerola Hannaleena; Aittomäki Kristiina; von Smitten Karl; Holli Kaija; Blomqvist Carl; Kallioniemi Olli-Pekka; Nevanlinna Heli
BARD1 variants Cys557Ser and Val507Met in breast cancer predisposition.
European journal of human genetics : EJHG 2006;14(2):167-72.
2006: Mononen Nina; Seppälä Eija H; Duggal Priya; Autio Ville; Ikonen Tarja; Ellonen Pekka; Saharinen Juha; Saarela Janna; Vihinen Mauno; Tammela Teuvo L J; Kallioniemi Olli; Bailey-Wilson Joan E; Schleutker Johanna
Profiling genetic variation along the androgen biosynthesis and metabolism pathways implicates several single nucleotide polymorphisms and their combinations as prostate cancer risk factors.
Cancer research 2006;66(2):743-7.
2006: Skotheim Rolf I; Autio Reija; Lind Guro E; Kraggerud Sigrid M; Andrews Peter W; Monni Outi; Kallioniemi Olli; Lothe Ragnhild A
Novel genomic aberrations in testicular germ cell tumors by array-CGH, and associated gene expression changes.
Cellular oncology : the official journal of the International Society for Cellular Oncology 2006;28(5-6):315-26.
2005: Kallioniemi Olli
Functional genomics and transcriptomics of prostate cancer: promises and limitations.
BJU international 2005;96 Suppl 2():10-5.
2005: Lugli Alessandro; Spichtin Hanspeter; Maurer Robert; Mirlacher Martina; Kiefer Jeff; Huusko Pia; Azorsa David; Terracciano Luigi; Sauter Guido; Kallioniemi Olli-P; Mousses Spyro; Tornillo Luigi
EphB2 expression across 138 human tumor types in a tissue microarray: high levels of expression in gastrointestinal cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(18):6450-8.
2005: Baffoe-Bonnie Agnes B; Smith Jeffrey R; Stephan Dietrich A; Schleutker Johanna; Carpten John D; Kainu Tommi; Gillanders Elizabeth M; Matikainen Mika; Teslovich Tanya M; Tammela Teuvo; Sood Raman; Balshem Andrew M; Scarborough Sheehan D; Xu Jianfeng; Isaacs William B; Trent Jeffrey M; Kallioniemi Olli-P; Bailey-Wilson Joan E
A major locus for hereditary prostate cancer in Finland: localization by linkage disequilibrium of a haplotype in the HPCX region.
Human genetics 2005;117(4):307-16.
2005: Skotheim Rolf I; Lind Guro E; Monni Outi; Nesland Jahn M; Abeler Vera M; Fosså Sophie D; Duale Nur; Brunborg Gunnar; Kallioniemi Olli; Andrews Peter W; Lothe Ragnhild A
Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development.
Cancer research 2005;65(13):5588-98.
2005: Antoniou A C; Pharoah P D P; Narod S; Risch H A; Eyfjord J E; Hopper J L; Olsson H; Johannsson O; Borg A; Pasini B; Radice P; Manoukian S; Eccles D M; Tang N; Olah E; Anton-Culver H; Warner E; Lubinski J; Gronwald J; Gorski B; Tulinius H; Thorlacius S; Eerola H; Nevanlinna H; Syrjäkoski K; Kallioniemi O-P; Thompson D; Evans C; Peto J; Lalloo F; Evans D G; Easton D F
Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies.
Journal of medical genetics 2005;42(7):602-3.
2005: Kilpivaara Outi; Bartkova Jirina; Eerola Hannaleena; Syrjäkoski Kirsi; Vahteristo Pia; Lukas Jiri; Blomqvist Carl; Holli Kaija; Heikkilä Päivi; Sauter Guido; Kallioniemi Olli-Pekka; Bartek Jiri; Nevanlinna Heli
Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients.
International journal of cancer. Journal international du cancer 2005;113(4):575-80.
2005: Rökman Annika; Baffoe-Bonnie Agnes B; Gillanders Elizabeth; Fredriksson Henna; Autio Ville; Ikonen Tarja; Gibbs Kenneth D; Jones Marypat; Gildea Derek; Freas-Lutz Diane; Markey Carol; Matikainen Mika P; Koivisto Pasi A; Tammela Teuvo L J; Kallioniemi Olli P; Trent Jeffrey; Bailey-Wilson Joan E; Schleutker Johanna
Hereditary prostate cancer in Finland: fine-mapping validates 3p26 as a major predisposition locus.
Human genetics 2005;116(1-2):43-50.
2005: Wolf Maija; Edgren Henrik; Muggerud Aslaug; Kilpinen Sami; Huusko Pia; Sørlie Therese; Mousses Spyro; Kallioniemi Olli
NMD microarray analysis for rapid genome-wide screen of mutated genes in cancer.
Cellular oncology : the official journal of the International Society for Cellular Oncology 2005;27(3):169-73.
2004: Syrjäkoski Kirsi; Kuukasjärvi Tuula; Waltering Kati; Haraldsson Karin; Auvinen Anssi; Borg Ake; Kainu Tommi; Kallioniemi Olli-P; Koivisto Pasi A
BRCA2 mutations in 154 finnish male breast cancer patients.
Neoplasia (New York, N.Y.) 2004;6(5):541-5.
2004: Huusko Pia; Ponciano-Jackson Damaris; Wolf Maija; Kiefer Jeff A; Azorsa David O; Tuzmen Sukru; Weaver Don; Robbins Christiane; Moses Tracy; Allinen Minna; Hautaniemi Sampsa; Chen Yidong; Elkahloun Abdel; Basik Mark; Bova G Steven; Bubendorf Lukas; Lugli Alessandro; Sauter Guido; Schleutker Johanna; Ozcelik Hilmi; Elowe Sabine; Pawson Tony; Trent Jeffrey M; Carpten John D; Kallioniemi Olli-P; Mousses Spyro
Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer.
Nature genetics 2004;36(9):979-83.
2004: Kilpivaara Outi; Vahteristo Pia; Falck Jacob; Syrjäkoski Kirsi; Eerola Hannaleena; Easton Douglas; Bartkova Jirina; Lukas Jiri; Heikkilä Päivi; Aittomäki Kristiina; Holli Kaija; Blomqvist Carl; Kallioniemi Olli-Pekka; Bartek Jiri; Nevanlinna Heli
CHEK2 variant I157T may be associated with increased breast cancer risk.
International journal of cancer. Journal international du cancer 2004;111(4):543-7.
2004: Järvinen Anna-Kaarina; Hautaniemi Sampsa; Edgren Henrik; Auvinen Petri; Saarela Janna; Kallioniemi Olli-P; Monni Outi
Are data from different gene expression microarray platforms comparable?
Genomics 2004;83(6):1164-8.
2004: Wolf Maija; Mousses Spyro; Hautaniemi Sampsa; Karhu Ritva; Huusko Pia; Allinen Minna; Elkahloun Abdel; Monni Outi; Chen Yidong; Kallioniemi Anne; Kallioniemi Olli-P
High-resolution analysis of gene copy number alterations in human prostate cancer using CGH on cDNA microarrays: impact of copy number on gene expression.
Neoplasia (New York, N.Y.) 2004;6(3):240-7.
2004: Srivastava Meera; Bubendorf Lukas; Raffeld Mark; Bucher Christoph; Torhorst Jochen; Sauter Guido; Olsen Cara; Kallioniemi Olli P; Eidelman Ofer; Pollard Harvey B
Prognostic impact of ANX7-GTPase in metastatic and HER2-negative breast cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(7):2344-50.
2004: Kallioniemi Olli
Medicine: profile of a tumour.
Nature 2004;428(6981):379-82.
2004: Weeraratna Ashani T; Becker Dorothea; Carr Kristen M; Duray Paul H; Rosenblatt Kevin P; Yang Sherry; Chen Yidong; Bittner Michael; Strausberg Robert L; Riggins Gregory J; Wagner Urs; Kallioniemi Olli P; Trent Jeffrey M; Morin Patrice J; Meltzer Paul S
Generation and analysis of melanoma SAGE libraries: SAGE advice on the melanoma transcriptome.
Oncogene 2004;23(12):2264-74.
2004: Huusko Pia; Juo Suh-Hang Hank; Gillanders Elizabeth; Sarantaus Laura; Kainu Tommi; Vahteristo Pia; Allinen Minna; Jones MaryPat; Rapakko Katrin; Eerola Hannaleena; Markey Carol; Vehmanen Paula; Gildea Derek; Freas-Lutz Diane; Blomqvist Carl; Leisti Jaakko; Blanco Guillermo; Puistola Ulla; Trent Jeffrey; Bailey-Wilson Joan; Winqvist Robert; Nevanlinna Heli; Kallioniemi Olli-P
Genome-wide scanning for linkage in Finnish breast cancer families.
European journal of human genetics : EJHG 2004;12(2):98-104.
2004: Syrjäkoski Kirsi; Kuukasjärvi Tuula; Auvinen Anssi; Kallioniemi Olli-P
CHEK2 1100delC is not a risk factor for male breast cancer population.
International journal of cancer. Journal international du cancer 2004;108(3):475-6.
2003: Skotheim Rolf I; Kallioniemi Anne; Bjerkhagen Bodil; Mertens Fredrik; Brekke Helge R; Monni Outi; Mousses Spyro; Mandahl Nils; Soeter Gunnar; Nesland Jahn M; Smeland Sigbjørn; Kallioniemi Olli-P; Lothe Ragnhild A
Topoisomerase-II alpha is upregulated in malignant peripheral nerve sheath tumors and associated with clinical outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(24):4586-91.
2003: Schleutker Johanna; Baffoe-Bonnie Agnes B; Gillanders Elizabeth; Kainu Tommi; Jones Mary-Pat; Freas-Lutz Diana; Markey Carol; Gildea Derek; Riedesel Erica; Albertus Julie; Gibbs Kenneth D; Matikainen Mika; Koivisto Pasi A; Tammela Teuvo; Bailey-Wilson Joan E; Trent Jeffrey M; Kallioniemi Olli-P
Genome-wide scan for linkage in finnish hereditary prostate cancer (HPC) families identifies novel susceptibility loci at 11q14 and 3p25-26.
The Prostate 2003;57(4):280-9.
2003: Hautaniemi Sampsa; Edgren Henrik; Vesanen Petri; Wolf Maija; Järvinen Anna-Kaarina; Yli-Harja Olli; Astola Jaakko; Kallioniemi Olli; Monni Outi
A novel strategy for microarray quality control using Bayesian networks.
Bioinformatics (Oxford, England) 2003;19(16):2031-8.
2003: Krajewska Maryla; Krajewski Stan; Banares Steven; Huang Xianshu; Turner Bruce; Bubendorf Lukas; Kallioniemi Olli-P; Shabaik Ahmed; Vitiello Antonella; Peehl Donna; Gao Guo-Jian; Reed John C
Elevated expression of inhibitor of apoptosis proteins in prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(13):4914-25.
2003: Mousses Spyro; Caplen Natasha J; Cornelison Robert; Weaver Don; Basik Mark; Hautaniemi Sampsa; Elkahloun Abdel G; Lotufo Roberto A; Choudary Ashish; Dougherty Edward R; Suh Ed; Kallioniemi Olli
RNAi microarray analysis in cultured mammalian cells.
Genome research 2003;13(10):2341-7.
2003: Skotheim Rolf I; Abeler Vera M; Nesland Jahn M; Fosså Sophie D; Holm Ruth; Wagner Urs; Flørenes Vivi Ann; Aass Nina; Kallioniemi Olli P; Lothe Ragnhild A
Candidate genes for testicular cancer evaluated by in situ protein expression analyses on tissue microarrays.
Neoplasia (New York, N.Y.) 2003;5(5):397-404.
2003: Hu Ying Chuan; Komorowski Richard A; Graewin Shannon; Hostetter Galen; Kallioniemi Olli-P; Pitt Henry A; Ahrendt Steven A
Thymidylate synthase expression predicts the response to 5-fluorouracil-based adjuvant therapy in pancreatic cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(11):4165-71.
2003: Ikonen T; Matikainen M P; Syrjäkoski K; Mononen N; Koivisto P A; Rökman A; Seppälä E H; Kallioniemi O-P; Tammela T L J; Schleutker J
BRCA1 and BRCA2 mutations have no major role in predisposition to prostate cancer in Finland.
Journal of medical genetics 2003;40(8):e98.
2003: Marchesani Marja; Hakkarainen Anna; Tuomainen Tomi-Pekka; Kaikkonen Jari; Pukkala Eero; Uimari Pekka; Seppälä Eija; Matikainen Mika; Kallioniemi Olli-P; Schleutker Johanna; Lehtimäki Terho; Salonen Jukka T
New paraoxonase 1 polymorphism I102V and the risk of prostate cancer in Finnish men.
Journal of the National Cancer Institute 2003;95(11):812-8.
2003: Antoniou A; Pharoah P D P; Narod S; Risch H A; Eyfjord J E; Hopper J L; Loman N; Olsson H; Johannsson O; Borg A; Pasini B; Radice P; Manoukian S; Eccles D M; Tang N; Olah E; Anton-Culver H; Warner E; Lubinski J; Gronwald J; Gorski B; Tulinius H; Thorlacius S; Eerola H; Nevanlinna H; Syrjäkoski K; Kallioniemi O-P; Thompson D; Evans C; Peto J; Lalloo F; Evans D G; Easton D F
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
American journal of human genetics 2003;72(5):1117-30.
2003: Kominsky Scott L; Argani Pedram; Korz Dorian; Evron Ella; Raman Venu; Garrett Elizabeth; Rein Alan; Sauter Guido; Kallioniemi Olli-P; Sukumar Saraswati
Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast.
Oncogene 2003;22(13):2021-33.
2003: Lehtonen R; Kiuru M; Rökman A; Ikonen T; Cunningham J M; Schaid D J; Matikainen M; Nupponen N N; Karhu A; Kallioniemi O-P; Thibodeau S N; Schleutker J; Aaltonen L A
No fumarate hydratase (FH) mutations in hereditary prostate cancer.
Journal of medical genetics 2003;40(3):e19.
2003: Syrjäkoski Kirsi; Hyytinen Eija-R; Kuukasjärvi Tuula; Auvinen Anssi; Kallioniemi Olli-P; Kainu Tommi; Koivisto Pasi A
Androgen receptor gene alterations in Finnish male breast cancer.
Breast cancer research and treatment 2003;77(2):167-70.
2003: Pollock Pamela M; Harper Ursula L; Hansen Katherine S; Yudt Laura M; Stark Mitchell; Robbins Christiane M; Moses Tracy Y; Hostetter Galen; Wagner Urs; Kakareka John; Salem Ghadi; Pohida Tom; Heenan Peter; Duray Paul; Kallioniemi Olli; Hayward Nicholas K; Trent Jeffrey M; Meltzer Paul S
High frequency of BRAF mutations in nevi.
Nature genetics 2003;33(1):19-20.
2002: van de Rijn Matt; Perou Charles M; Tibshirani Rob; Haas Phillippe; Kallioniemi Olli; Kononen Juha; Torhorst Joachim; Sauter Guido; Zuber Markus; Köchli Ossi R; Mross Frank; Dieterich Holger; Seitz Rob; Ross Doug; Botstein David; Brown Pat
Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome.
The American journal of pathology 2002;161(6):1991-6.
2002: Bärlund Maarit; Monni Outi; Weaver J Donald; Kauraniemi Päivikki; Sauter Guido; Heiskanen Mervi; Kallioniemi Olli-P; Kallioniemi Anne
Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer.
Genes, chromosomes & cancer 2002;35(4):311-7.
2002: Hyman Elizabeth; Kauraniemi Päivikki; Hautaniemi Sampsa; Wolf Maija; Mousses Spyro; Rozenblum Ester; Ringnér Markus; Sauter Guido; Monni Outi; Elkahloun Abdel; Kallioniemi Olli-P; Kallioniemi Anne
Impact of DNA amplification on gene expression patterns in breast cancer.
Cancer research 2002;62(21):6240-5.
2002: Mononen Nina; Ikonen Tarja; Autio Ville; Rökman Annika; Matikainen Mika P; Tammela Teuvo L J; Kallioniemi Olli-P; Koivisto Pasi A; Schleutker Johanna
Androgen receptor CAG polymorphism and prostate cancer risk.
Human genetics 2002;111(2):166-71.
2002: Vahteristo Pia; Bartkova Jirina; Eerola Hannaleena; Syrjäkoski Kirsi; Ojala Salla; Kilpivaara Outi; Tamminen Anitta; Kononen Juha; Aittomäki Kristiina; Heikkilä Päivi; Holli Kaija; Blomqvist Carl; Bartek Jiri; Kallioniemi Olli-P; Nevanlinna Heli
A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer.
American journal of human genetics 2002;71(2):432-8.
2002: Rökman Annika; Ikonen Tarja; Seppälä Eija H; Nupponen Nina; Autio Ville; Mononen Nina; Bailey-Wilson Joan; Trent Jeffrey; Carpten John; Matikainen Mika P; Koivisto Pasi A; Tammela Teuvo L J; Kallioniemi Olli-P; Schleutker Johanna
Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer.
American journal of human genetics 2002;70(5):1299-304.
2002: Skotheim Rolf I; Monni Outi; Mousses Spyro; Fosså Sophie D; Kallioniemi Olli-P; Lothe Ragnhild A; Kallioniemi Anne
New insights into testicular germ cell tumorigenesis from gene expression profiling.
Cancer research 2002;62(8):2359-64.
2002: Krajewska Maryla; Zapata Juan M; Meinhold-Heerlein Ivo; Hedayat Hirad; Monks Anne; Bettendorf Herta; Shabaik Ahmed; Bubendorf Lukas; Kallioniemi Olli-P; Kim Hoguen; Reifenberger Guido; Reed John C; Krajewski Stanislaw
Expression of Bcl-2 family member Bid in normal and malignant tissues.
Neoplasia (New York, N.Y.) 2002;4(2):129-40.
2002: Mousses Spyro; Bubendorf Lukas; Wagner Urs; Hostetter Galen; Kononen Juha; Cornelison Robert; Goldberger Natalie; Elkahloun Abdel G; Willi Niels; Koivisto Pasi; Ferhle William; Raffeld Mark; Sauter Guito; Kallioniemi Olli-P
Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays.
Cancer research 2002;62(5):1256-60.
2002: Rozenblum Ester; Vahteristo Pia; Sandberg Therese; Bergthorsson Jon Thor; Syrjakoski Kirsi; Weaver Don; Haraldsson Karin; Johannsdottir Hrefna Kristin; Vehmanen Paula; Nigam Savita; Golberger Natalie; Robbins Christiane; Pak Evgenia; Dutra Amalia; Gillander Elizabeth; Stephan Dietrich A; Bailey-Wilson Joan; Juo Suh-Hang Hank; Kainu Tommi; Arason Adalgeir; Barkardottir Rosa Bjork; Nevanlinna Heli; Borg Ake; Kallioniemi Olli-P
A genomic map of a 6-Mb region at 13q21-q22 implicated in cancer development: identification and characterization of candidate genes.
Human genetics 2002;110(2):111-21.
2002: Mousses Spyro; Kallioniemi Anne; Kauraniemi Päivikki; Elkahloun Abdel; Kallioniemi Olli-P
Clinical and functional target validation using tissue and cell microarrays.
Current opinion in chemical biology 2002;6(1):97-101.
2002: Carpten J; Nupponen N; Isaacs S; Sood R; Robbins C; Xu J; Faruque M; Moses T; Ewing C; Gillanders E; Hu P; Bujnovszky P; Makalowska I; Baffoe-Bonnie A; Faith D; Smith J; Stephan D; Wiley K; Brownstein M; Gildea D; Kelly B; Jenkins R; Hostetter G; Matikainen M; Schleutker J; Klinger K; Connors T; Xiang Y; Wang Z; De Marzo A; Papadopoulos N; Kallioniemi O-P; Burk R; Meyers D; Grönberg H; Meltzer P; Silverman R; Bailey-Wilson J; Walsh P; Isaacs W; Trent J
Germline mutations in the ribonuclease L gene in families showing linkage with HPC1.
Nature genetics 2002;30(2):181-4.
2002: Grigoryan Artyom M; Dougherty Edward R; Kononen Juha; Bubendorf Lukas; Hostetter Galen; Kallioniemi Olli
Morphological spot counting from stacked images for automated analysis of gene copy numbers by fluorescence in situ hybridization.
Journal of biomedical optics 2002;7(1):109-22.
2002: Monni Outi; Hautaniemi Sampsa; Kallioniemi Olli
[Gene chip technique and associated bioinformatics]
Duodecim; lääketieteellinen aikakauskirja 2002;118(11):1157-66.
2002: Kallioniemi Olli
[From gene chips to biochips: challenges and possibilities of the new biotechnology]
Duodecim; lääketieteellinen aikakauskirja 2002;118(11):1149-56.
2001: Torhorst J; Bucher C; Kononen J; Haas P; Zuber M; Köchli O R; Mross F; Dieterich H; Moch H; Mihatsch M; Kallioniemi O P; Sauter G
Tissue microarrays for rapid linking of molecular changes to clinical endpoints.
The American journal of pathology 2001;159(6):2249-56.
2001: Ikonen T; Matikainen M; Mononen N; Hyytinen E R; Helin H J; Tommola S; Tammela T L; Pukkala E; Schleutker J; Kallioniemi O P; Koivisto P A
Association of E-cadherin germ-line alterations with prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(11):3465-71.
2001: Barkardottir R B; Sarantaus L; Arason A; Vehmanen P; Bendahl P O; Kainu T; Syrjäkoski K; Krahe R; Huusko P; Pyrhönen S; Holli K; Kallioniemi O P; Egilsson V; Kere J; Nevanlinna H
Haplotype analysis in Icelandic and Finnish BRCA2 999del5 breast cancer families.
European journal of human genetics : EJHG 2001;9(10):773-9.
2001: Mousses S; Wagner U; Chen Y; Kim J W; Bubendorf L; Bittner M; Pretlow T; Elkahloun A G; Trepel J B; Kallioniemi O P
Failure of hormone therapy in prostate cancer involves systematic restoration of androgen responsive genes and activation of rapamycin sensitive signaling.
Oncogene 2001;20(46):6718-23.
2001: Forus A; D'Angelo A; Henriksen J; Merla G; Maelandsmo G M; Flørenes V A; Olivieri S; Bjerkehagen B; Meza-Zepeda L A; del Vecchio Blanco F; Müller C; Sanvito F; Kononen J; Nesland J M; Fodstad Ø; Reymond A; Kallioniemi O P; Arrigoni G; Ballabio A; Myklebost O; Zollo M
Amplification and overexpression of PRUNE in human sarcomas and breast carcinomas-a possible mechanism for altering the nm23-H1 activity.
Oncogene 2001;20(47):6881-90.
2001: Nocito A; Kononen J; Kallioniemi O P; Sauter G
Tissue microarrays (TMAs) for high-throughput molecular pathology research.
International journal of cancer. Journal international du cancer 2001;94(1):1-5.
2001: Monni O; Hyman E; Mousses S; Barlund M; Kallioniemi A; Kallioniemi O P
From chromosomal alterations to target genes for therapy: integrating cytogenetic and functional genomic views of the breast cancer genome.
Seminars in cancer biology 2001;11(5):395-401.
2001: Rökman A; Ikonen T; Mononen N; Autio V; Matikainen M P; Koivisto P A; Tammela T L; Kallioniemi O P; Schleutker J
ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer.
Cancer research 2001;61(16):6038-41.
2001: Mononen N; Ikonen T; Syrjäkoski K; Matikainen M; Schleutker J; Tammela T L; Koivisto P A; Kallioniemi O P
A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland.
British journal of cancer 2001;84(10):1344-7.
2001: Matikaine M P; Pukkala E; Schleutker J; Tammela T L; Koivisto P; Sankila R; Kallioniemi O P
Relatives of prostate cancer patients have an increased risk of prostate and stomach cancers: a population-based, cancer registry study in Finland.
Cancer causes & control : CCC 2001;12(3):223-30.
2001: Srivastava M; Bubendorf L; Srikantan V; Fossom L; Nolan L; Glasman M; Leighton X; Fehrle W; Pittaluga S; Raffeld M; Koivisto P; Willi N; Gasser T C; Kononen J; Sauter G; Kallioniemi O P; Srivastava S; Pollard H B
ANX7, a candidate tumor suppressor gene for prostate cancer.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(8):4575-80.
2001: Kallioniemi O P; Wagner U; Kononen J; Sauter G
Tissue microarray technology for high-throughput molecular profiling of cancer.
Human molecular genetics 2001;10(7):657-62.
2001: Kallioniemi O P
Biochip technologies in cancer research.
Annals of medicine 2001;33(2):142-7.
2001: Hedenfalk I; Duggan D; Chen Y; Radmacher M; Bittner M; Simon R; Meltzer P; Gusterson B; Esteller M; Kallioniemi O P; Wilfond B; Borg A; Trent J; Raffeld M; Yakhini Z; Ben-Dor A; Dougherty E; Kononen J; Bubendorf L; Fehrle W; Pittaluga S; Gruvberger S; Loman N; Johannsson O; Olsson H; Sauter G
Gene-expression profiles in hereditary breast cancer.
The New England journal of medicine 2001;344(8):539-48.
2001: Rökman A; Koivisto P A; Matikainen M P; Kuukasjärvi T; Poutiainen M; Helin H J; Karhu R; Kallioniemi O P; Schleutker J
Genetic changes in familial prostate cancer by comparative genomic hybridization.
The Prostate 2001;46(3):233-9.
2001: Moch H; Kononen T; Kallioniemi O P; Sauter G
Tissue microarrays: what will they bring to molecular and anatomic pathology?
Advances in anatomic pathology 2001;8(1):14-20.
2001: Rapakko K; Allinen M; Syrjäkoski K; Vahteristo P; Huusko P; Vähäkangas K; Eerola H; Kainu T; Kallioniemi O P; Nevanlinna H; Winqvist R
Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites.
British journal of cancer 2001;84(1):116-9.
2001: Srivastava M; Bubendorf L; Nolan L; Glasman M; Leighton X; Miller G; Fehrle W; Raffeld M; Eidelman O; Kallioniemi O P; Srivastava S; Pollard H B
ANX7 as a bio-marker in prostate and breast cancer progression.
Disease markers 2001;17(2):115-20.
2001: Heiskanen M; Kononen J; Bärlund M; Torhorst J; Sauter G; Kallioniemi A; Kallioniemi O
CGH, cDNA and tissue microarray analyses implicate FGFR2 amplification in a small subset of breast tumors.
Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology 2001;22(4):229-34.
2000: Wolf M; El-Rifai W; Tarkkanen M; Kononen J; Serra M; Eriksen E F; Elomaa I; Kallioniemi A; Kallioniemi O P; Knuutila S
Novel findings in gene expression detected in human osteosarcoma by cDNA microarray.
Cancer genetics and cytogenetics 2000;123(2):128-32.
2000: Schleutker J; Matikainen M; Smith J; Koivisto P; Baffoe-Bonnie A; Kainu T; Gillanders E; Sankila R; Pukkala E; Carpten J; Stephan D; Tammela T; Brownstein M; Bailey-Wilson J; Trent J; Kallioniemi O P
A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: frequent HPCX linkage in families with late-onset disease.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(12):4810-5.
2000: Sallinen S L; Sallinen P K; Haapasalo H K; Helin H J; Helén P T; Schraml P; Kallioniemi O P; Kononen J
Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques.
Cancer research 2000;60(23):6617-22.
2000: Palmberg C; Koivisto P; Kakkola L; Tammela T L; Kallioniemi O P; Visakorpi T
Androgen receptor gene amplification at primary progression predicts response to combined androgen blockade as second line therapy for advanced prostate cancer.
The Journal of urology 2000;164(6):1992-5.
2000: Jiang F; Desper R; Papadimitriou C H; Schäffer A A; Kallioniemi O P; Richter J; Schraml P; Sauter G; Mihatsch M J; Moch H
Construction of evolutionary tree models for renal cell carcinoma from comparative genomic hybridization data.
Cancer research 2000;60(22):6503-9.
2000: Mononen N; Syrjäkoski K; Matikainen M; Tammela T L; Schleutker J; Kallioniemi O P; Trapman J; Koivisto P A
Two percent of Finnish prostate cancer patients have a germ-line mutation in the hormone-binding domain of the androgen receptor gene.
Cancer research 2000;60(22):6479-81.
2000: Bowen C; Bubendorf L; Voeller H J; Slack R; Willi N; Sauter G; Gasser T C; Koivisto P; Lack E E; Kononen J; Kallioniemi O P; Gelmann E P
Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression.
Cancer research 2000;60(21):6111-5.
2000: Sarantaus L; Huusko P; Eerola H; Launonen V; Vehmanen P; Rapakko K; Gillanders E; Syrjäkoski K; Kainu T; Vahteristo P; Krahe R; Pääkkönen K; Hartikainen J; Blomqvist C; Löppönen T; Holli K; Ryynänen M; Bützow R; Borg A; Wasteson Arver B; Holmberg E; Mannermaa A; Kere J; Kallioniemi O P; Winqvist R; Nevanlinna H
Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland.
European journal of human genetics : EJHG 2000;8(10):757-63.
2000: Matikainen M P; Sankila R; Schleutker J; Kallioniemi O P; Pukkala E
Nationwide cancer family ascertainment using Finnish Cancer Registry data on family names and places of birth for 35,761 prostate cancer patients.
International journal of cancer. Journal international du cancer 2000;88(2):307-12.
2000: Syrjäkoski K; Vahteristo P; Eerola H; Tamminen A; Kivinummi K; Sarantaus L; Holli K; Blomqvist C; Kallioniemi O P; Kainu T; Nevanlinna H
Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients.
Journal of the National Cancer Institute 2000;92(18):1529-31.
2000: Richter J; Wagner U; Kononen J; Fijan A; Bruderer J; Schmid U; Ackermann D; Maurer R; Alund G; Knönagel H; Rist M; Wilber K; Anabitarte M; Hering F; Hardmeier T; Schönenberger A; Flury R; Jäger P; Fehr J L; Schraml P; Moch H; Mihatsch M J; Gasser T; Kallioniemi O P; Sauter G
High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer.
The American journal of pathology 2000;157(3):787-94.
2000: Forozan F; Mahlamäki E H; Monni O; Chen Y; Veldman R; Jiang Y; Gooden G C; Ethier S P; Kallioniemi A; Kallioniemi O P
Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data.
Cancer research 2000;60(16):4519-25.
2000: Kainu T; Juo S H; Desper R; Schaffer A A; Gillanders E; Rozenblum E; Freas-Lutz D; Weaver D; Stephan D; Bailey-Wilson J; Kallioniemi O P; Tirkkonen M; Syrjäkoski K; Kuukasjärvi T; Koivisto P; Karhu R; Holli K; Arason A; Johannesdottir G; Bergthorsson J T; Johannsdottir H; Egilsson V; Barkardottir R B; Johannsson O; Haraldsson K; Sandberg T; Holmberg E; Grönberg H; Olsson H; Borg A; Vehmanen P; Eerola H; Heikkila P; Pyrhönen S; Nevanlinna H
Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(17):9603-8.
2000: Bärlund M; Forozan F; Kononen J; Bubendorf L; Chen Y; Bittner M L; Torhorst J; Haas P; Bucher C; Sauter G; Kallioniemi O P; Kallioniemi A
Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis.
Journal of the National Cancer Institute 2000;92(15):1252-9.
2000: Desper R; Jiang F; Kallioniemi O P; Moch H; Papadimitriou C H; Schäffer A A
Distance-based reconstruction of tree models for oncogenesis.
Journal of computational biology : a journal of computational molecular cell biology 2000;7(6):789-803.
1999: Forozan F; Veldman R; Ammerman C A; Parsa N Z; Kallioniemi A; Kallioniemi O P; Ethier S P
Molecular cytogenetic analysis of 11 new breast cancer cell lines.
British journal of cancer 1999;81(8):1328-34.
1999: Koivisto P A; Schleutker J; Helin H; Ehren-van Eekelen C; Kallioniemi O P; Trapman J
Androgen receptor gene alterations and chromosomal gains and losses in prostate carcinomas appearing during finasteride treatment for benign prostatic hyperplasia.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(11):3578-82.
1999: Lee S K; Anzick S L; Choi J E; Bubendorf L; Guan X Y; Jung Y K; Kallioniemi O P; Kononen J; Trent J M; Azorsa D; Jhun B H; Cheong J H; Lee Y C; Meltzer P S; Lee J W
A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors in vivo.
The Journal of biological chemistry 1999;274(48):34283-93.
1999: Bubendorf L; Kolmer M; Kononen J; Koivisto P; Mousses S; Chen Y; Mahlamäki E; Schraml P; Moch H; Willi N; Elkahloun A G; Pretlow T G; Gasser T C; Mihatsch M J; Sauter G; Kallioniemi O P
Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays.
Journal of the National Cancer Institute 1999;91(20):1758-64.
1999: Schraml P; Kononen J; Bubendorf L; Moch H; Bissig H; Nocito A; Mihatsch M J; Kallioniemi O P; Sauter G
Tissue microarrays for gene amplification surveys in many different tumor types.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(8):1966-75.
1999: Matikainen M P; Schleutker J; Mörsky P; Kallioniemi O P; Tammela T L
Detection of subclinical cancers by prostate-specific antigen screening in asymptomatic men from high-risk prostate cancer families.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(6):1275-9.
1999: Ingvarsson S; Agnarsson B A; Sigbjornsdottir B I; Kononen J; Kallioniemi O P; Barkardottir R B; Kovatich A J; Schwarting R; Hauck W W; Huebner K; McCue P A
Reduced Fhit expression in sporadic and BRCA2-linked breast carcinomas.
Cancer research 1999;59(11):2682-9.
1999: Moch H; Schraml P; Bubendorf L; Mirlacher M; Kononen J; Gasser T; Mihatsch M J; Kallioniemi O P; Sauter G
High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma.
The American journal of pathology 1999;154(4):981-6.
1999: Bubendorf L; Kononen J; Koivisto P; Schraml P; Moch H; Gasser T C; Willi N; Mihatsch M J; Sauter G; Kallioniemi O P
Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays.
Cancer research 1999;59(4):803-6.
1999: Kjellman M; Roshani L; Teh B T; Kallioniemi O P; Höög A; Gray S; Farnebo L O; Holst M; Bäckdahl M; Larsson C
Genotyping of adrenocortical tumors: very frequent deletions of the MEN1 locus in 11q13 and of a 1-centimorgan region in 2p16.
The Journal of clinical endocrinology and metabolism 1999;84(2):730-5.
1999: Mahdy E; Yoshihiro S; Zech L; Wester K; Pan Y; Busch C; Döhner H; Kallioniemi O; Bergerheim U; Malmström P U
Comparison of comparative genomic hybridization, fluorescence in situ hybridization and flow cytometry in urinary bladder cancer.
Anticancer research 1999;19(1A):7-12.
1999: Tirkkonen M; Kainu T; Loman N; Jóhannsson O T; Olsson H; Barkardóttir R B; Kallioniemi O P; Borg A
Somatic genetic alterations in BRCA2-associated and sporadic male breast cancer.
Genes, chromosomes & cancer 1999;24(1):56-61.
1999: Nevanlinna H; Kallioniemi O P
[Susceptibility genes of familial breast cancer in Finland]
Duodecim; lääketieteellinen aikakauskirja 1999;115(21):2365-74.
1999: Moch H; Schraml P; Bubendorf L; Mirlacher M; Kononen J; Gasser T; Mihatsch M J; Kallioniemi O P; Sauter G
[Identification of prognostic parameters for renal cell carcinoma by cDNA arrays and cell chips]
Verhandlungen der Deutschen Gesellschaft für Pathologie 1999;83():225-32.
1999: Desper R; Jiang F; Kallioniemi O P; Moch H; Papadimitriou C H; Schäffer A A
Inferring tree models for oncogenesis from comparative genome hybridization data.
Journal of computational biology : a journal of computational molecular cell biology 1999;6(1):37-51.
1998: Xu J; Meyers D; Freije D; Isaacs S; Wiley K; Nusskern D; Ewing C; Wilkens E; Bujnovszky P; Bova G S; Walsh P; Isaacs W; Schleutker J; Matikainen M; Tammela T; Visakorpi T; Kallioniemi O P; Berry R; Schaid D; French A; McDonnell S; Schroeder J; Blute M; Thibodeau S; Grönberg H; Emanuelsson M; Damber J E; Bergh A; Jonsson B A; Smith J; Bailey-Wilson J; Carpten J; Stephan D; Gillanders E; Amundson I; Kainu T; Freas-Lutz D; Baffoe-Bonnie A; Van Aucken A; Sood R; Collins F; Brownstein M; Trent J
Evidence for a prostate cancer susceptibility locus on the X chromosome.
Nature genetics 1998;20(2):175-9.
1998: Collins C; Rommens J M; Kowbel D; Godfrey T; Tanner M; Hwang S I; Polikoff D; Nonet G; Cochran J; Myambo K; Jay K E; Froula J; Cloutier T; Kuo W L; Yaswen P; Dairkee S; Giovanola J; Hutchinson G B; Isola J; Kallioniemi O P; Palazzolo M; Martin C; Ericsson C; Pinkel D; Albertson D; Li W B; Gray J W
Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(15):8703-8.
1998: Kononen J; Bubendorf L; Kallioniemi A; Bärlund M; Schraml P; Leighton S; Torhorst J; Mihatsch M J; Sauter G; Kallioniemi O P
Tissue microarrays for high-throughput molecular profiling of tumor specimens.
Nature medicine 1998;4(7):844-7.
1998: Tirkkonen M; Tanner M; Karhu R; Kallioniemi A; Isola J; Kallioniemi O P
Molecular cytogenetics of primary breast cancer by CGH.
Genes, chromosomes & cancer 1998;21(3):177-84.
1998: Koivisto P; Kolmer M; Visakorpi T; Kallioniemi O P
Androgen receptor gene and hormonal therapy failure of prostate cancer.
The American journal of pathology 1998;152(1):1-9.
1998: Bärlund M; Nupponen N N; Karhu R; Tanner M M; Paavola P; Kallioniemi O P; Kallioniemi A
Molecular cytogenetic mapping of 24 CEPH YACs and 24 gene-specific large insert probes to chromosome 17.
Cytogenetics and cell genetics 1998;82(3-4):189-91.
1997: Mahlamäki E H; Höglund M; Gorunova L; Karhu R; Dawiskiba S; Andrén-Sandberg A; Kallioniemi O P; Johansson B
Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 12p, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancer.
Genes, chromosomes & cancer 1997;20(4):383-91.
1997: Bärlund M; Tirkkonen M; Forozan F; Tanner M M; Kallioniemi O; Kallioniemi A
Increased copy number at 17q22-q24 by CGH in breast cancer is due to high-level amplification of two separate regions.
Genes, chromosomes & cancer 1997;20(4):372-6.
1997: Vehmanen P; Friedman L S; Eerola H; McClure M; Ward B; Sarantaus L; Kainu T; Syrjäkoski K; Pyrhönen S; Kallioniemi O P; Muhonen T; Luce M; Frank T S; Nevanlinna H
Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes.
Human molecular genetics 1997;6(13):2309-15.
1997: Forozan F; Karhu R; Kononen J; Kallioniemi A; Kallioniemi O P
Genome screening by comparative genomic hybridization.
Trends in genetics : TIG 1997;13(10):405-9.
1997: Karhu R; Knuutila S; Kallioniemi O P; Siltonen S; Aine R; Vilpo L; Vilpo J
Frequent loss of the 11q14-24 region in chronic lymphocytic leukemia: a study by comparative genomic hybridization. Tampere CLL Group.
Genes, chromosomes & cancer 1997;19(4):286-90.
1997: Anzick S L; Kononen J; Walker R L; Azorsa D O; Tanner M M; Guan X Y; Sauter G; Kallioniemi O P; Trent J M; Meltzer P S
AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer.
Science (New York, N.Y.) 1997;277(5328):965-8.
1997: Karhu R; Kähkönen M; Kuukasjärvi T; Pennanen S; Tirkkonen M; Kallioniemi O
Quality control of CGH: impact of metaphase chromosomes and the dynamic range of hybridization.
Cytometry 1997;28(3):198-205.
1997: Kuukasjärvi T; Karhu R; Tanner M; Kähkönen M; Schäffer A; Nupponen N; Pennanen S; Kallioniemi A; Kallioniemi O P; Isola J
Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer.
Cancer research 1997;57(8):1597-604.
1997: Tirkkonen M; Johannsson O; Agnarsson B A; Olsson H; Ingvarsson S; Karhu R; Tanner M; Isola J; Barkardottir R B; Borg A; Kallioniemi O P
Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations.
Cancer research 1997;57(7):1222-7.
1997: Kuukasjärvi T; Tanner M; Pennanen S; Karhu R; Kallioniemi O P; Isola J
Genetic changes in intraductal breast cancer detected by comparative genomic hybridization.
The American journal of pathology 1997;150(4):1465-71.
1997: Koivisto P; Kononen J; Palmberg C; Tammela T; Hyytinen E; Isola J; Trapman J; Cleutjens K; Noordzij A; Visakorpi T; Kallioniemi O P
Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer.
Cancer research 1997;57(2):314-9.
1997: Kallioniemi O P
Linking chromosomal clues.
Nature genetics 1997;15(1):5-6.
1997: Matikainen M; Schleutker J; Visakorpi T; Kallioniemi O P
[ Hereditary prostate cancer with gene location]
Duodecim; lääketieteellinen aikakauskirja 1997;113(6):461-2.
1997: Palmberg C; Koivisto P; Hyytinen E; Isola J; Visakorpi T; Kallioniemi O P; Tammela T
Androgen receptor gene amplification in a recurrent prostate cancer after monotherapy with the nonsteroidal potent antiandrogen Casodex (bicalutamide) with a subsequent favorable response to maximal androgen blockade.
European urology 1997;31(2):216-9.
1997: Hyytinen E R; Thalmann G N; Zhau H E; Karhu R; Kallioniemi O P; Chung L W; Visakorpi T
Genetic changes associated with the acquisition of androgen-independent growth, tumorigenicity and metastatic potential in a prostate cancer model.
British journal of cancer 1997;75(2):190-5.
1996: Tirkkonen M; Karhu R; Kallioniemi O; Isola J
Evaluation of camera requirements for comparative genomic hybridization.
Cytometry 1996;25(4):394-8.
1996: Smith J R; Freije D; Carpten J D; Grönberg H; Xu J; Isaacs S D; Brownstein M J; Bova G S; Guo H; Bujnovszky P; Nusskern D R; Damber J E; Bergh A; Emanuelsson M; Kallioniemi O P; Walker-Daniels J; Bailey-Wilson J E; Beaty T H; Meyers D A; Walsh P C; Collins F S; Trent J M; Isaacs W B
Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search.
Science (New York, N.Y.) 1996;274(5291):1371-4.
1996: Lothe R A; Karhu R; Mandahl N; Mertens F; Saeter G; Heim S; Borresen-Dale A L; Kallioniemi O P
Gain of 17q24-qter detected by comparative genomic hybridization in malignant tumors from patients with von Recklinghausen's neurofibromatosis.
Cancer research 1996;56(20):4778-81.
1996: Kjellman M; Kallioniemi O P; Karhu R; Höög A; Farnebo L O; Auer G; Larsson C; Bäckdahl M
Genetic aberrations in adrenocortical tumors detected using comparative genomic hybridization correlate with tumor size and malignancy.
Cancer research 1996;56(18):4219-23.
1996: Tanner M M; Tirkkonen M; Kallioniemi A; Isola J; Kuukasjärvi T; Collins C; Kowbel D; Guan X Y; Trent J; Gray J W; Meltzer P; Kallioniemi O P
Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer.
Cancer research 1996;56(15):3441-5.
1996: Heiskanen M; Kallioniemi O; Palotie A
Fiber-FISH: experiences and a refined protocol.
Genetic analysis : biomolecular engineering 1996;12(5-6):179-84.
1996: Paavonen K; Horelli-Kuitunen N; Chilov D; Kukk E; Pennanen S; Kallioniemi O P; Pajusola K; Olofsson B; Eriksson U; Joukov V; Palotie A; Alitalo K
Novel human vascular endothelial growth factor genes VEGF-B and VEGF-C localize to chromosomes 11q13 and 4q34, respectively.
Circulation 1996;93(6):1079-82.
1996: Hakama M; Holli K; Visakorpi T; Pekola M; Kallioniemi O P
Low biological aggressiveness of screen-detected lung cancers may indicate over-diagnosis.
International journal of cancer. Journal international du cancer 1996;66(1):6-10.
1996: Haapasalo H; Hyytinen E; Sallinen P; Helin H; Kallioniemi O P; Isola J
c-erbB-2 in astrocytomas: infrequent overexpression by immunohistochemistry and absence of gene amplification by fluorescence in situ hybridization.
British journal of cancer 1996;73(5):620-3.
1996: Kere J; Kallioniemi O P
[From pedigree analysis to gene defects]
Duodecim; lääketieteellinen aikakauskirja 1996;112(4):297-305.
1996: Koivisto P; Visakorpi T; Kallioniemi O P
Androgen receptor gene amplification: a novel molecular mechanism for endocrine therapy resistance in human prostate cancer.
Scandinavian journal of clinical and laboratory investigation. Supplementum 1996;226():57-63.
1996: Kallioniemi O P; Visakorpi T
Genetic basis and clonal evolution of human prostate cancer.
Advances in cancer research 1996;68():225-55.
1995: Tanner M M; Tirkkonen M; Kallioniemi A; Holli K; Collins C; Kowbel D; Gray J W; Kallioniemi O P; Isola J
Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implications.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(12):1455-61.
1995: Koivisto P; Hyytinen E; Palmberg C; Tammela T; Visakorpi T; Isola J; Kallioniemi O P
Analysis of genetic changes underlying local recurrence of prostate carcinoma during androgen deprivation therapy.
The American journal of pathology 1995;147(6):1608-14.
1995: Heiskanen M; Hellsten E; Kallioniemi O P; Mäkelä T P; Alitalo K; Peltonen L; Palotie A
Visual mapping by fiber-FISH.
Genomics 1995;30(1):31-6.
1995: Isola J J; Kallioniemi O P; Chu L W; Fuqua S A; Hilsenbeck S G; Osborne C K; Waldman F M
Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer.
The American journal of pathology 1995;147(4):905-11.
1995: Laan M; Kallioniemi O P; Hellsten E; Alitalo K; Peltonen L; Palotie A
Mechanically stretched chromosomes as targets for high-resolution FISH mapping.
Genome research 1995;5(1):13-20.
1995: Visakorpi T; Hyytinen E; Koivisto P; Tanner M; Keinänen R; Palmberg C; Palotie A; Tammela T; Isola J; Kallioniemi O P
In vivo amplification of the androgen receptor gene and progression of human prostate cancer.
Nature genetics 1995;9(4):401-6.
1995: Stokke T; Collins C; Kuo W L; Kowbel D; Shadravan F; Tanner M; Kallioniemi A; Kallioniemi O P; Pinkel D; Deaven L
A physical map of chromosome 20 established using fluorescence in situ hybridization and digital image analysis.
Genomics 1995;26(1):134-7.
1995: Kallioniemi A; Kallioniemi O P; Citro G; Sauter G; DeVries S; Kerschmann R; Caroll P; Waldman F
Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization.
Genes, chromosomes & cancer 1995;12(3):213-9.
1995: Van Den Berg C; Guan X Y; Von Hoff D; Jenkins R; Bittner; Griffin C; Kallioniemi O; Visakorpi; McGill; Herath J
DNA sequence amplification in human prostate cancer identified by chromosome microdissection: potential prognostic implications.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(1):11-8.
1995: Hakama M; Holli K; Isola J; Kallioniemi O P; Kärkkäinen A; Visakorpi T; Pukkala E; Saarenmaa I; Geiger U; Ikkala J
Aggressiveness of screen-detected breast cancers.
Lancet 1995;345(8944):221-4.
1995: du Manoir S; Kallioniemi O P; Lichter P; Piper J; Benedetti P A; Carothers A D; Fantes J A; García-Sagredo J M; Gerdes T; Giollant M
Hardware and software requirements for quantitative analysis of comparative genomic hybridization.
Cytometry 1995;19(1):4-9.
1995: Piper J; Rutovitz D; Sudar D; Kallioniemi A; Kallioniemi O P; Waldman F M; Gray J W; Pinkel D
Computer image analysis of comparative genomic hybridization.
Cytometry 1995;19(1):10-26.
1995: Visakorpi T; Kallioniemi A H; Syvänen A C; Hyytinen E R; Karhu R; Tammela T; Isola J J; Kallioniemi O P
Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization.
Cancer research 1995;55(2):342-7.
1995: Rytkönen E M; Halila R; Laan M; Saksela M; Kallioniemi O P; Palotie A; Raivio K O
The human gene for xanthine dehydrogenase (XDH) is localized on chromosome band 2q22.
Cytogenetics and cell genetics 1995;68(1-2):61-3.
1994: Heiskanen M; Karhu R; Hellsten E; Peltonen L; Kallioniemi O P; Palotie A
High resolution mapping using fluorescence in situ hybridization to extended DNA fibers prepared from agarose-embedded cells.
BioTechniques 1994;17(5):928-9, 932-3.
1994: Visakorpi T; Hyytinen E; Kallioniemi A; Isola J; Kallioniemi O P
Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization.
The American journal of pathology 1994;145(3):624-30.
1994: Kallioniemi O P; Kallioniemi A; Piper J; Isola J; Waldman F M; Gray J W; Pinkel D
Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors.
Genes, chromosomes & cancer 1994;10(4):231-43.
1994: Kallioniemi O P; Visakorpi T; Holli K; Isola J J; Rabinovitch P S
Automated peak detection and cell cycle analysis of flow cytometric DNA histograms.
Cytometry 1994;16(3):250-5.
1994: Hyytinen E; Visakorpi T; Kallioniemi A; Kallioniemi O P; Isola J J
Improved technique for analysis of formalin-fixed, paraffin-embedded tumors by fluorescence in situ hybridization.
Cytometry 1994;16(2):93-9.
1994: Kallioniemi A; Kallioniemi O P; Piper J; Tanner M; Stokke T; Chen L; Smith H S; Pinkel D; Gray J W; Waldman F M
Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(6):2156-60.
1994: Kallioniemi O P; Kallioniemi A; Mascio L; Sudar D; Pinkel D; Deaven L; Gray J
Physical mapping of chromosome 17 cosmids by fluorescence in situ hybridization and digital image analysis.
Genomics 1994;20(1):125-8.
1994: Isola J J; Holli K; Oksa H; Teramoto Y; Kallioniemi O P
Elevated erbB-2 oncoprotein levels in preoperative and follow-up serum samples define an aggressive disease course in patients with breast cancer.
Cancer 1994;73(3):652-8.
1994: Gray J W; Collins C; Henderson I C; Isola J; Kallioniemi A; Kallioniemi O P; Nakamura H; Pinkel D; Stokke T; Tanner M
Molecular cytogenetics of human breast cancer.
Cold Spring Harbor symposia on quantitative biology 1994;59():645-52.
1993: Siitonen S M; Kallioniemi O P; Helin H J; Isola J J
Prognostic value of cells with more than 5c DNA content in node-negative breast cancer as determined by image cytometry from tissue sections.
Human pathology 1993;24(12):1348-53.
1993: Mohamed A N; Macoska J A; Kallioniemi A; Kallioniemi O P; Waldman F; Ratanatharathorn V; Wolman S R
Extrachromosomal gene amplification in acute myeloid leukemia; characterization by metaphase analysis, comparative genomic hybridization, and semi-quantitative PCR.
Genes, chromosomes & cancer 1993;8(3):185-9.
1993: Siitonen S M; Kallioniemi O P; Isola J J
Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer.
The American journal of pathology 1993;142(4):1081-9.
1993: Kallioniemi O P; Kallioniemi A; Sudar D; Rutovitz D; Gray J W; Waldman F; Pinkel D
Comparative genomic hybridization: a rapid new method for detecting and mapping DNA amplification in tumors.
Seminars in cancer biology 1993;4(1):41-6.
1993: Isola J; Weitz S; Visakorpi T; Holli K; Shea R; Khabbaz N; Kallioniemi O P
Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(1):36-43.
1993: Shankey T V; Kallioniemi O P; Koslowski J M; Lieber M L; Mayall B H; Miller G; Smith G J
Consensus review of the clinical utility of DNA content cytometry in prostate cancer.
Cytometry 1993;14(5):497-500.
1993: Visakorpi T; Kallioniemi O P; Koivula T; Isola J
New prognostic factors in prostatic carcinoma.
European urology 1993;24(4):438-49.
1992: Gray J W; Kallioniemi A; Kallioniemi O; Pallavicini M; Waldman F; Pinkel D
Molecular cytogenetics: diagnosis and prognostic assessment.
Current opinion in biotechnology 1992;3(6):623-31.
1992: Visakorpi T; Kallioniemi O P; Koivula T; Harvey J; Isola J
Expression of epidermal growth factor receptor and ERBB2 (HER-2/Neu) oncoprotein in prostatic carcinomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1992;5(6):643-8.
1992: Kallioniemi A; Kallioniemi O P; Sudar D; Rutovitz D; Gray J W; Waldman F; Pinkel D
Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors.
Science (New York, N.Y.) 1992;258(5083):818-21.
1992: Isola J; Visakorpi T; Holli K; Kallioniemi O P
Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients.
Journal of the National Cancer Institute 1992;84(14):1109-14.
1992: Collan Y; Klemi P; Kallioniemi O P; Joensuu H; Nordling S; Eskelinen M
Significance of variation in DNA flow cytometric analyses from paraffin-embedded breast cancers. Evaluation of the grading efficiency of ploidy determination, DNA index, and S-phase fraction.
Pathology, research and practice 1992;188(4-5):581-6.
1992: Kallioniemi O P; Kallioniemi A; Kurisu W; Thor A; Chen L C; Smith H S; Waldman F M; Pinkel D; Gray J W
ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(12):5321-5.
1992: Matsumura K; Kallioniemi A; Kallioniemi O; Chen L; Smith H S; Pinkel D; Gray J; Waldman F M
Deletion of chromosome 17p loci in breast cancer cells detected by fluorescence in situ hybridization.
Cancer research 1992;52(12):3474-7.
1992: Visakorpi T; Kallioniemi O P; Heikkinen A; Koivula T; Isola J
Small subgroup of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation.
Journal of the National Cancer Institute 1992;84(11):883-7.
1992: Kallioniemi A; Kallioniemi O P; Waldman F M; Chen L C; Yu L C; Fung Y K; Smith H S; Pinkel D; Gray J W
Detection of retinoblastoma gene copy number in metaphase chromosomes and interphase nuclei by fluorescence in situ hybridization.
Cytogenetics and cell genetics 1992;60(3-4):190-3.
1991: Kallioniemi O P; Holli K; Visakorpi T; Koivula T; Helin H H; Isola J J
Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer.
International journal of cancer. Journal international du cancer 1991;49(5):650-5.
1991: Hyöty M; Visakorpi T; Kallioniemi O P; Mattila J; Laippala P; Nordback I
Prognostic value of analysis of DNA in pancreatic adenocarcinoma by flow cytometry.
The European journal of surgery = Acta chirurgica 1991;157(10):595-600.
1991: Visakorpi T; Kallioniemi O P; Paronen I Y; Isola J J; Heikkinen A I; Koivula T A
Flow cytometric analysis of DNA ploidy and S-phase fraction from prostatic carcinomas: implications for prognosis and response to endocrine therapy.
British journal of cancer 1991;64(3):578-82.
1991: Laustiola K E; Kotamäki M; Lassila R; Kallioniemi O P; Manninen V
Cigarette smoking alters sympathoadrenal regulation by decreasing the density of beta 2-adrenoceptors. A study of monitored smoking cessation.
Journal of cardiovascular pharmacology 1991;17(6):923-8.
1991: Isolauri J; Mattila J; Kallioniemi O P
Primary undifferentiated small cell carcinoma of the esophagus: clinicopathological and flow cytometric evaluation of eight cases.
Journal of surgical oncology 1991;46(3):174-7.
1991: Gray J W; Lucas J; Kallioniemi O; Kallioniemi A; Kuo W L; Straume T; Tkachuk D; Tenjin T; Weier H U; Pinkel D
Applications of fluorescence in situ hybridization in biological dosimetry and detection of disease-specific chromosome aberrations.
Progress in clinical and biological research 1991;372():399-411.
1991: Kallioniemi O P; Visakorpi T; Holli K; Heikkinen A; Isola J; Koivula T
Improved prognostic impact of S-phase values from paraffin-embedded breast and prostate carcinomas after correcting for nuclear slicing.
Cytometry 1991;12(5):413-21.
1991: Kallioniemi O P; Holli K; Visakorpi T; Koivula T; Helin H; Isola J
[New studies on breast cancer to predict disease outcome and clinical use of these new tests]
Duodecim; lääketieteellinen aikakauskirja 1991;107(11):907-16.
1990: Isola J; Kallioniemi O P; Korte J M; Wahlström T; Aine R; Helle M; Helin H
Steroid receptors and Ki-67 reactivity in ovarian cancer and in normal ovary: correlation with DNA flow cytometry, biochemical receptor assay, and patient survival.
The Journal of pathology 1990;162(4):295-301.
1990: Kallioniemi O P; Joensuu H; Klemi P; Koivula T
Inter-laboratory comparison of DNA flow cytometric results from paraffin-embedded breast carcinomas.
Breast cancer research and treatment 1990;17(1):59-61.
1990: Isola J; Helin H; Kallioniemi O P
Immunoelectron-microscopic localization of a proliferation-associated antigen Ki-67 in MCF-7 cells.
The Histochemical journal 1990;22(9):498-506.
1990: Jaakkola O; Kallioniemi O P; Nikkari T
Lipoprotein metabolism of human and rabbit arterial cells in primary culture.
European heart journal 1990;11 Suppl E():128-33.
1990: Blanco G; Holli K; Heikkinen M; Kallioniemi O P; Taskinen P
Prognostic factors in recurrent breast cancer: relationships to site of recurrence, disease-free interval, female sex steroid receptors, ploidy and histological malignancy grading.
British journal of cancer 1990;62(1):142-6.
1990: Isola J J; Helin H J; Helle M J; Kallioniemi O P
Evaluation of cell proliferation in breast carcinoma. Comparison of Ki-67 immunohistochemical study, DNA flow cytometric analysis, and mitotic count.
Cancer 1990;65(5):1180-4.
1990: Pontén J; Holmberg L; Trichopoulos D; Kallioniemi O P; Kvåle G; Wallgren A; Taylor-Papadimitriou J
Biology and natural history of breast cancer.
International journal of cancer. Supplement = Journal international du cancer. Supplement 1990;5():5-21.
1990: Ojala A; Kallioniemi O P; Wigren T; Kallioniemi A; Mattila J; Lehtinen M; Koivula T
Flow cytometric analysis of tumour DNA profile related to response to radiotherapy and survival in inoperable lung cancer.
Acta oncologica (Stockholm, Sweden) 1990;29(8):983-8.
1989: Joensuu H; Kallioniemi O P
Different opinions on classification of DNA histograms produced from paraffin-embedded tissue.
Cytometry 1989;10(6):711-7.
1989: Punnonen R; Kallioniemi O P; Mattila J; Väyrynen M; Koivula T
Primary invasive and in situ vaginal carcinoma. Flow cytometric analysis of DNA aneuploidy and cell proliferation from archival paraffin-embedded tissue.
European journal of obstetrics, gynecology, and reproductive biology 1989;32(3):247-51.
1989: Räsänen L; Hyöty H; Lehto M; Kallioniemi O P; Huupponen T; Tuomilehto-Wolf E; Kaprio E; Leinikki P
Suppression of autologous mixed leukocyte reaction in type 1 diabetes mellitus by in vivo-activated T lymphocytes.
Clinical immunology and immunopathology 1989;52(3):406-13.
1989: Helin H J; Helle M J; Kallioniemi O P; Isola J J
Immunohistochemical determination of estrogen and progesterone receptors in human breast carcinoma. Correlation with histopathology and DNA flow cytometry.
Cancer 1989;63(9):1761-7.
1989: Paavonen J; Miettinen A; Heinonen P K; Aaran R K; Teisala K; Aine R; Punnonen R; Laine S; Kallioniemi O P; Lehtinen M
Serum CA 125 in acute pelvic inflammatory disease.
British journal of obstetrics and gynaecology 1989;96(5):574-9.
1989: Lehtinen T; Aine R; Lehtinen M; Kallioniemi O P; Leino T; Hakala T; Leinikki P; Alavaikko M
Flow cytometric DNA analysis of 199 histologically favourable or unfavourable non-Hodgkin lymphomas.
The Journal of pathology 1989;157(1):27-36.
1989: Kallioniemi O P; Kärkkäinen A; Mattila J; Auvinen O; Koivula T; Hakama M
[Mammographic screening confirmation of breast cancer biological characteristics--a flow cytometric study]
Duodecim; lääketieteellinen aikakauskirja 1989;105(18):1532-8.
1989: Punnonen R; Kallioniemi O P; Mattila J; Koivula T
Prognostic assessment in stage I ovarian cancer using a discriminant analysis with clinicopathological and DNA flow cytometric data.
Gynecologic and obstetric investigation 1989;27(4):213-6.
1989: Autio I; Malo-Ranta U; Kallioniemi O P; Nikkari T
Cultured bovine aortic endothelial cells secrete factor(s) chemotactic for aortic smooth muscle cells.
Artery 1989;16(2):72-83.
1989: Kallioniemi O P; Hietanen T; Blanco G; Alavaikko M; Mattila J; Lehtinen M; Lauslahti K; Koivula T
[Prognosis of breast tumors by DNA flow cytometric analysis]
Duodecim; lääketieteellinen aikakauskirja 1989;105(1):38-49.
1989: Lehtinen M; Kulomaa P; Kallioniemi O P; Paavonen J; Leinikki P
Analysis of DNA synthesis in herpes simplex virus infected cells by dual parameter flow cytometry.
Archives of virology 1989;107(3-4):215-23.
1988: Kallioniemi O P; Kärkkäinen A; Auvinen O; Mattila J; Koivula T; Hakama M
DNA flow cytometric analysis indicates that many breast cancers detected in the first round of mammographic screening have a low malignant potential.
International journal of cancer. Journal international du cancer 1988;42(5):697-702.
1988: Kallioniemi O P; Blanco G; Alavaikko M; Hietanen T; Mattila J; Lauslahti K; Lehtinen M; Koivula T
Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction. A proposed classification of DNA histograms in breast cancer.
Cancer 1988;62(10):2183-90.
1988: Kallioniemi O P; Oksa H; Aaran R K; Hietanen T; Lehtinen M; Koivula T
Serum CA 15-3 assay in the diagnosis and follow-up of breast cancer.
British journal of cancer 1988;58(2):213-5.
1988: Kallioniemi O P
Comparison of fresh and paraffin-embedded tissue as starting material for DNA flow cytometry and evaluation of intratumor heterogeneity.
Cytometry 1988;9(2):164-9.
1988: Räsänen L; Hyöty H; Lehto M; Kallioniemi O P; Antonen J; Huupponen T; Karjalainen J; Leinikki P
Defective autologous mixed leukocyte reaction in newly diagnosed type 1 diabetes mellitus.
Clinical and experimental immunology 1988;71(3):470-4.
1988: Jaakkola O; Kallioniemi O P; Nikkari T
Lipoprotein uptake in primary cell cultures of rabbit atherosclerotic lesions. A fluorescence microscopic and flow cytometric study.
Atherosclerosis 1988;69(2-3):257-68.
1988: Kallioniemi O P; Punnonen R; Mattila J; Lehtinen M; Koivula T
Prognostic significance of DNA index, multiploidy, and S-phase fraction in ovarian cancer.
Cancer 1988;61(2):334-9.
1988: Lehtinen M; Paavonen J; Ylä-Outinen A; Romppanen U; Kulomaa P; Kallioniemi O P; Lehtinen T; Aine R; Lauslahti K; Vesterinen E
[Flow cytometry of cervical cell changes]
Duodecim; lääketieteellinen aikakauskirja 1988;104(7):517-24.
1988: Ashorn P; Kallioniemi O P; Hietanen T; Ashorn R; Krohn K
Elevated serum HMFG antigen levels in breast and ovarian cancer patients measured with a sandwich ELISA.
International journal of cancer. Supplement = Journal international du cancer. Supplement 1988;2():28-33.
1988: Lehtinen M; Wigren T; Lehtinen T; Kallioniemi O P; Aine R; Aaran R K; Ojala A
Correlation between serum tumor marker levels and tumor proliferation in small cell lung cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1988;9(6):287-92.
1988: Kallioniemi O P; Mattila J; Punnonen R; Koivula T
DNA ploidy level and cell cycle distribution in ovarian cancer: relation to histopathological features of the tumor.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 1988;7(1):1-11.
1987: Kallioniemi O P; Blanco G; Alavaikko M; Hietanen T; Mattila J; Lauslahti K; Koivula T
Tumour DNA ploidy as an independent prognostic factor in breast cancer.
British journal of cancer 1987;56(5):637-42.
1987: Lehtinen T; Lehtinen M; Aine R; Kallioniemi O P; Leino T; Hakala T; Leinikki P; Alavaikko M
Nuclear DNA content of non-endemic Burkitt's lymphoma.
Journal of clinical pathology 1987;40(10):1201-5.
1987: Kallioniemi O P; Nieminen M M; Lehtinen J; Veneskoski T; Koivula T
Increased serum placental-like alkaline phosphatase activity in smokers originates from the lungs.
European journal of respiratory diseases 1987;71(3):170-6.
1987: Heinonen P K; Kallioniemi O P; Koivula T
Comparison of CA 125 and placental alkaline phosphatase as ovarian tumor markers.
Tumori 1987;73(3):301-2.
1987: Kallioniemi O P; Hietanen T; Mattila J; Lehtinen M; Lauslahti K; Koivula T
Aneuploid DNA content and high S-phase fraction of tumour cells are related to poor prognosis in patients with primary breast cancer.
European journal of cancer & clinical oncology 1987;23(3):277-82.
1985: Kallioniemi O P; Heinonen P K; Pystynen P; Koivula T
Evaluation of the value of fluorometric serum heat stable alkaline phosphatase assay in patients operated on for ovarian tumors.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1985;6(3):213-9.
1984: Kallioniemi O P; Jaakkola O; Nikkari S T; Nikkari T
Growth properties and composition of cytoskeletal and cytocontractile proteins in aortic cells isolated and cultured from normal and atherosclerotic rabbits.
Atherosclerosis 1984;52(1):13-26.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Olli Kallioniemi

Research Profile (preview)

Disorders

Chemicals & Drugs

Procedures

Devices

Physiology

Geographic Areas

Phenomena

Anatomy

Concepts & Ideas

Genes & Molecular Sequences

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Olli Kallioniemi (preview)

All Publications